Racial disparities in #ProstateCancer in the UK and the USA

nature.com/articles/s41...

paper emphasizes that addressing these inequities requires systemic change: dismantling structural racism, increasing representation in clinical research and healthcare workforce

@silkegillessen.bsky.social

Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial

t.co/tzTr4MmoZi

TRAP Results showed a median progression-free survival (PFS) of 6.4 months, with 39% of patients maintaining PFS beyond 12 months.

Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical Prostatectomy

jnm.snmjournals.org/content/66/3...

The results suggest intraoperative ex vivo PET/CT could be useful for margin assessment, though further trials are needed. #ProstateCancer

Physics-Informed Autoencoder for Prostate Tissue Microstructure Profiling with Hybrid Multidimensional MRI

pubs.rsna.org/doi/full/10....

#ProstateCancer

@barbaramelao.bsky.social
@achoud72.bsky.social
@yukselurun.bsky.social
@drnataliagandur.bsky.social

High-purity CTC RNA sequencing identifies #ProstateCancer lineage phenotypes prognostic for clinical outcomes out in CANCER DISCOVERY

aacrjournals.org/cancerdiscov...

@silkegillessen.bsky.social
@aureliusomlin.bsky.social
@barbaramelao.bsky.social
@achoud72.bsky.social
@yukselurun.bsky.social

Cancer Statistics Just Out for 2025 out on American Cancer Society Journals
acsjournals.onlinelibrary.wiley.com/doi/epdf/10....

#ProstateCancer has one of the highest contemporary survival rates at 97%, followed closely by testicular cancer (95%) and melanoma (94%)

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial

europeanurology.com/article/S030...

Results provide valuable insights for treatment decision-making, highlighting better urinary and sexual outcomes with SBRT

AR alterations inform circulating tumor DNA detection in metastatic castration resistant #ProstateCancer patients out in Nature Communications
www.nature.com/articles/s41...

Highlights ctDNA positivity as a strong prognostic marker for poor survival in mCRPC, even with AR inhibitor treatments.

Study investigates how androgen-dependent #ProstateCancer evades immune detection by downregulating major histocompatibility complex class I.The researchers found that late-stage prostate cancer responds better to immunotherapy when MHCI expression is elevated

aacrjournals.org/cancerdiscov...

A warm welcome to Dr. Aurelius Omlin🇨🇭@aureliusomlin.bsky.social to BlueSky!

Medical Uro-Oncologist & Co-Organiser of international Advanced Prostate Cancer Consensus Conference (APCCC) in Lugano🇨🇭

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social

Simulation of Focal Boosting in Online Adaptive MRI-Guided SBRT in Locally Advanced #ProstateCancer w/Seminal Vesicle Involvement

MRI guidance was effective in delivering precise tx despite constraints

www.practicalradonc.org/article/S187...

@achoud72.bsky.social
@barbaramelao.bsky.social

Study used 2sample Mendelian randomization approach to investigate the causal relationship between various dietary habits and #ProstateCancer risk

bmccancer.biomedcentral.com/articles/10....

@oncoalert.bsky.social
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social

A warm welcome to APC Society President Dr. Silke Gillessen @silkegillessen.bsky.social To BlueSky

Director of the Oncology Institute of S. Switzerland🇨🇭& Head of Dpt of Medical Oncology

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social

Frailty in Older Adults with #ProstateCancer

euoncology.europeanurology.com/article/S258...

Tailored tx, including geriatric interventions & supportive care, are crucial for frail patients

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social

Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized #ProstateCancer Undergoing ADT With Rad tx

Findings suggest variability in ADT’s hypoxia-modifying effects might undermine the biomarkers’ predictive utility.

@achoud72.bsky.social

www.redjournal.org/article/S036...